Management tracks

Obesity play Orexigen Therapeutics Inc. (NASDAQ:OREX) hired Tom Cannell as chief commercial officer. He will replace Mark Booth, who is departing. Cannell most recently was head of the global human health operating model team at Merck & Co. Inc. (NYSE:MRK).

Cancer company Sorrento Therapeutics Inc. (NASDAQ:SRNE) hired George Ng as EVP and chief legal officer. Previously, Ng was SVP and general counsel at BioDelivery Sciences International Inc. (NASDAQ:BDSI). ...